OTC asthma inhaler endangers patients by encouraging substandard treatment – News-Medical.net

OTC asthma inhaler endangers patients by encouraging substandard treatment
News-Medical.net
An over-the-counter (OTC) asthma inhaler up for approval by the U.S. Food & Drug Administration (FDA) endangers patients by encouraging substandard treatment, according to Allergy & Asthma Network Mothers of Asthmatics (AANMA), a leading nonprofit 
Seasons change, so do asthma triggersScoopSanDiego.com

all 4 news articles »

View full post on asthma – Google News

Boston Scientific reports encouraging data from asthma trial – TMC Net

Boston Scientific reports encouraging data from asthma trial
TMC Net
The research in severe asthma (RISA) trial is the third in a series of clinical trials that have completed five years of follow-up for patients treated with bronchial thermoplasty. In summary, bronchial thermoplasty has demonstrated a strong long-term
Long-term Safety and Effectiveness of Bronchial Thermoplasty Demonstrated in PR Newswire (press release)

all 16 news articles »

View full post on asthma – Google News